AIDS non-profit takes Gilead fight to SCOTUS

A non-profit called AIDS Healthcare Foundation (AHF) has filed a petition for certiorari with the US Supreme Court in a patent dispute with Gilead.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Big Pharma

Antitrust HIV drugs case should be arbitrated, argue Gilead, BMS

16 February 2021 Gilead Sciences and Bristol-Myers Squibb have said that a suit alleging they were involved in a long-running scheme to block generic competition and keep HIV medication prices artificially high is “legally defective”.

Europe

Gilead HIV drug not entitled to SPC, says UK court

20 September 2018 The English High Court has ruled that Gilead’s drug Truvada is not entitled to a supplementary protection certificate because it failed to meet the standards set out by Europe’s highest court earlier this year.

Americas

Federal Circuit backs dismissal of AIDS drug suit

14 May 2018 The US Court of Appeals for the Federal Circuit has affirmed the dismissal of a clash between a non-profit organisation and Gilead over patents covering HIV drugs.

More features

To disclose or not: Pharma patents face new AI reality

Trade secrets go global: How brand owners face a high-stakes battlefront

Killing the golden goose of US drug innovation (Part II): Drug pricing myths

Former pharma GC brings in-house perspective to McGuireWoods

Sandoz eyes US biosimilar launch as Regeneron settles

Killing the golden goose of US drug innovation (Part I): Follow the money

Buchalter brings in new partner to head up medtech

Trump’s march-in rights threat: Why pharma is rethinking collaborations

AIDS non-profit takes Gilead fight to SCOTUS

More on this story

Editor's picks

Editor's picks

More features